BMI1 promotes the progression of laryngeal squamous cell carcinoma

Oral Oncology

Volumn 47, Issue 6, 2011, Pages 472-481

  Chen, Hui ^a   Zhou, Liang ^a   Wan, Guanglun ^b   Dou, Tonghai ^c   Tian, Jie ^a  

^a FUDAN UNIVERSITY   (China)

^b ANHUI PROVINCIAL HOSPITAL   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

BMI1; Laryngeal squamous cell carcinoma; Progression; Proliferation; Radiochemotherapy sensitization

Indexed keywords

BMI1 PROTEIN; CISPLATIN;

ADULT; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CANCER GROWTH; CARCINOGENICITY; CASE REPORT; CELL CYCLE; CELL PROLIFERATION; CHEMORADIOTHERAPY; DISEASE COURSE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IN VIVO STUDY; LARYNX CARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; STAINING; TUMOR GROWTH; WESTERN BLOTTING;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL LINE, TUMOR; DISEASE PROGRESSION; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; HUMANS; LARYNGEAL NEOPLASMS; MICE; MICE, INBRED NOD; MICE, SCID; NUCLEAR PROTEINS; PROGNOSIS; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS;

EID: 79958029138     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2011.03.016     Document Type: Article

References (39)

1. Spivakov M, Fisher AG. Epigenetic signatures of stem-cell identity. Nat Rev Genet 2007;8:263-71. (Pubitemid 46439288)
2. Park IK, Morrison SJ, Clarke MF. Bmi1, stem cells, and senescence regulation. J Clin Invest 2004;113:175-9. (Pubitemid 38544200)
3. Park IK, Qian D, Kiel M, Becker MW, Pihalja M, Weissman IL, et al. BMI-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 2003;423:302-5. (Pubitemid 40852701)
4. Bruggeman SW, Valk-Lingbeek ME, van der Stoop PP, Jacobs JJ, Kieboom K, Tanger E, et al. Ink4a and Arf differentially affect cell proliferation and neural stem cell self-renewal in Bmi1-deficient mice. Genes Dev 2005;19:1438-43. (Pubitemid 41003010)
5. Pietersen AM, Evers B, Prasad AA, Tanger E, Cornelissen-Steijger P, Jonker J, et al. Bmi1 regulates stem cells and proliferation and differentiation of committed cells in mammary epithelium. Curr Biol 2008;18:1094-9.
6. Lessard J, Sauvageau G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cell. Nature 2003;423:255-60. (Pubitemid 40852690)
7. Abdouh M, Facchino S, Chatoo W, Balasingam V, Ferreira J, Bernier G. BMI1 sustains human glioblastoma multiforme stem cell renewal. J Neurosci 2009;29:8884-96.
8. Kim JH, Yoon SY, Jeong SH, Kim SY, Moon SK, Joo JH, et al. Overexpression of Bmi-1 oncoprotein correlates with axillary lymph node metastases in invasive ductal breast cancer. Breast 2004;13:383-8. (Pubitemid 39549787)
9. Kim JH, Yoon SY, Kim CN, Joo JH, Moon SK, Choe IS, et al. The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a / p14ARF proteins. Cancer Lett 2004;203:217-24. (Pubitemid 38058689)
10. Glinsky GV, Berezovska O, Glinskii AB. Microarray analysis identifies a deathfrom- cancer signature predicting therapy failure in patients with multiple types of cancer. J Clin Invest 2005;115:1503-21. (Pubitemid 40814659)
11. Mihic-Probst D, Kuster A, Kilgus S, Bode-Lesniewska B, Ingold-Heppner B, Leung C, et al. Consistent expression of the stem cell renewal factor BMI-1 in primary and metastatic melanoma. Int J Cancer 2007;121:1764-70. (Pubitemid 47417295)
12. Song LB, Zeng MS, Liao WT, Zhang L, Mo HY, Liu WL, et al. Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. Cancer Res 2006;66:6225-32.
13. Becker M, Korn C, Sienerth AR, Voswinckel R, Luetkenhaus K, Ceteci F, et al. Polycomb group protein Bmi1 is required for growth of RAF driven non-smallcell lung cancer. PLoS One 2009;4:e4230.
14. Kang MK, Kim RH, Kim SJ, Yip FK, Shin KH, Dimri GP, et al. Elevated BMI-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival. Br J Cancer 2007;96:126-33. (Pubitemid 46094649)
15. Valk-Lingbeek ME, Bruggeman SW, van Lohuizen M. Stem cells and cancer: the polycomb connection. Cell 2004;118:409-18. (Pubitemid 39485661)
16. Alonso L, Fuchs E. Stem cells of the skin epithelium. Proc Natl Acad Sci USA 2003;100(Suppl 1):11830-5. (Pubitemid 37205891)
17. Vormittag L, Thurnher D, Geleff S, Pammer J, Heiduschka G, Brunner M, et al. Co-expression of BMI-1 and podoplanin predicts overall survival in patients with squamous cell carcinoma of the head and neck treated with radio(chemo)therapy. Int J Radiat Oncol Biol Phys 2009;73:913-8.
18. Li DW, Tang HM, Fan JW, Yan DW, Zhou CZ, Li SX, et al. Expression level of Bmi-1 oncoprotein is associated with progression and prognosis in colon cancer. J Cancer Res Clin Oncol 2010;136:997-1006.
19. Hayry V, Makinen LK, Atula T, Sariola H, Makitie A, Leivo I, et al. Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue. Br J Cancer 2010;102:892-7.
20. Choi YJ, Choi YL, Cho EY, Shin YK, Sung KW, Hwang YK, et al. Expression of Bmi-1 protein in tumor tissues is associated with favorable prognosis in breast cancer patients. Breast Cancer Res Treat 2009;113:83-93.
21. Dimri GP, Martinez JL, Jacobs JJ, Keblusek P, Itahana K, Van Lohuizen M, et al. The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells. Cancer Res 2002;62:4736-45.
22. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001;414:105-11. (Pubitemid 33041634)
23. Song W, Tao K, Li H, Jin C, Song Z, Li J, et al. Bmi-1 is related to proliferation, survival and poor prognosis in pancreatic cancer. Cancer Sci 2010;101:1754-60.
24. Lee K, Adhikary G, Balasubramanian S, Gopalakrishnan R, McCormick T, Dimri GP, et al. Expression of Bmi-1 in epidermis enhances cell survival by altering cell cycle regulatory protein expression and inhibiting apoptosis. J Invest Dermatol 2008;128:9-17. (Pubitemid 350249374)
25. Liu L, Andrews LG, Tollefsbol TO. Loss of the human polycomb group protein BMI1 promotes cancer-specific cell death. Oncogene 2006;25:4370-5. (Pubitemid 44100507)
26. Qin L, Zhang X, Zhang L, Feng Y, Weng GX, Li MZ, et al. Downregulation of BMI-1 enhances 5-fluorouracil-induced apoptosis in nasopharyngeal carcinoma cells. Biochem Biophys Res Commun 2008;371:531-5.
27. Yu Q, Su B, Liu D, Liu B, Fan Y, Wang Y, et al. Antisense RNA-mediated suppression of Bmi-1 gene expression inhibits the proliferation of lung cancer cell line A549. Oligonucleotides 2007;17:327-35. (Pubitemid 47463364)
28. Jiang Y, Su B, Meng X, Liu C, Liu B, Liu D, et al. Effect of siRNA-mediated silencing of Bmi-1 gene expression on HeLa cells. Cancer Sci 2010;101:379-86.
29. Cui H, Ma J, Ding J, Li T, Alam G, Ding HF. Bmi-1 regulates the differentiation and clonogenic self-renewal of I-type neuroblastoma cells in a concentration-dependent manner. J Biol Chem 2006;281:34696-704. (Pubitemid 46036675)
30. Alajez NM, Shi W, Hui AB, Yue S, Ng R, Lo KW, et al. Targeted depletion of BMI1 sensitizes tumor cells to P53-mediated apoptosis in response to radiation therapy. Cell Death Differ 2009;16:1469-79.
31. Li W, Li Y, Tan Y, Ma K, Cui J. Bmi-1 is critical for the proliferation and invasiveness of gastric carcinoma cells. J Gastroenterol Hepatol 2010;25:568-75.
32. Lee K, Adhikary G, Balasubramanian S, Gopalakrishnan R, McCormick T, Dimri GP, et al. Expression of Bmi-1 in epidermis enhances cell survival by altering cell cycle regulatory protein expression and inhibiting apoptosis. J Invest Dermatol 2008;128:9-17. (Pubitemid 350249374)
33. Chen YC, Chang CJ, Hsu HS, Chen YW, Tai LK, Tseng LM, et al. Inhibition of tumorigenicity and enhancement of radiochemosensitivity in head and neck squamous cell cancer-derived ALDH1-positive cells by knockdown of Bmi-1. Oral Oncol 2010;46:158-65.
34. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA 2007;104:973-8. (Pubitemid 46154721)
35. Chatoo W, Abdouh M, David J, Champagne MP, Ferreira J, Rodier F, et al. The polycomb group gene Bmi1 regulates antioxidant defenses in neurons by repressing p53 pro-oxidant activity. J Neurosci 2009;29:529-42.
36. Sun Y, Hegamyer G, Cheng YJ, Hildesheim A, Chen JY, Chen IH, et al. An infrequent point mutation of the p53 gene in human nasopharyngeal carcinoma. Proc Natl Acad Sci USA 1992;89:6516-20.
37. Hu L, Hofmann J, Lu Y, Mills GB, Jaffe RB. Inhibition of phosphatidylinositol 30- kinase increases efficacy of paclitaxel in in vitro and in vivo ovarian cancer models. Cancer Res 2002;62:1087-92. (Pubitemid 34160292)
38. Clark AS, West K, Streicher S, Dennis PA. Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells. Mol Cancer Ther 2002;1:707-17.
39. Guo WJ, Zeng MS, Yadav A, Song LB, Guo BH, Band V, et al. Mel-18 acts as a tumor suppressor by repressing Bmi-1 expression and down-regulating Akt activity in breast cancer cells. Cancer Res 2007;67:5083-9.